Novavax’s Covid-19 vaccine gets US nod as latest pandemic weapon

As the FDA approves the first Covid-19 vaccine of this kind, EU officials continue to evaluate Novavax’s shot as a booster for adults.
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
Photo: Dado Ruvic/Reuters/Ritzau Scanpix
By Fiona Rutherford, bloomberg

Novavax Inc.’s Covid-19 vaccine was cleared by US regulators, giving Americans another tool against the virus as cases start to rise again.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading